Lesinurad

CAS: 878672-00-5

Ref. TM-T6875

Produktinformation

• Name: Lesinurad
• Synonyme: RDEA594, 2-((5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid, 2-[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]acetic acid, 2-[[5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid, Acetic acid, 2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, Acetic acid, [[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, Lesinida, Rdea 594, Read 594, Zurampic
• CAS: 878672-00-5

Beschreibung

Lesinurad (RDEA594) is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 404.28
• Formel: C₁₇H₁₄BrN₃O₂S
• Reinheit: 99.83%
• Farbe/Form: Solid